Partial volume correction analysis for 11C-UCB-J PET studies of Alzheimer's disease
Purpose: 11C-UCB-J PET imaging, targeting synaptic vesicle glycoprotein 2A (SV2A), has been shown to be a useful indicator of synaptic density in Alzheimer's disease (AD). For SV2A imaging, a decrease in apparent tracer uptake is often due to the combination of gray-matter (GM) atrophy and SV2A...
Main Authors: | Yihuan Lu, Takuya Toyonaga, Mika Naganawa, Jean-Dominique Gallezot, Ming-Kai Chen, Adam P. Mecca, Christopher H. van Dyck, Richard E. Carson |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | NeuroImage |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1053811921005255 |
Similar Items
-
Principal component analysis of synaptic density measured with [11C]UCB-J PET in early Alzheimer’s disease
by: Ryan S. O'Dell, et al.
Published: (2023-01-01) -
Association of Aβ deposition and regional synaptic density in early Alzheimer’s disease: a PET imaging study with [11C]UCB-J
by: Ryan S. O’Dell, et al.
Published: (2021-01-01) -
Identifying brain networks in synaptic density PET (11C-UCB-J) with independent component analysis
by: Xiaotian T. Fang, et al.
Published: (2021-08-01) -
Feasibility of imaging synaptic density in the human spinal cord using [11C]UCB-J PET
by: Samantha Rossano, et al.
Published: (2022-05-01) -
Drug characteristics derived from kinetic modeling: combined 11C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A
by: Mika Naganawa, et al.
Published: (2022-11-01)